Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Joel Sainsous"'
Autor:
Didier Blanchard, Franck Paganelli, Didier Champagnac, Hervé Le Breton, Patrick Dupouy, Raphael Dauphin, Philippe Castellant, Nicolas Delarche, Anne Lyuycx-Bore, Luc Maillard, Róbert Gábor Kiss, Philippe Druelles, Antoine Gommeaux, Jarosław Wójcik, Marie Claude Morice, Michel Schneeberger, Erwan Bressolette, Alain Kermarrec, Joel Sainsous, Paul Barragan, Romain Didier, Olivier Darremont, Hakim Ben Amer, Gilles Levy, Alain Furber, Thomas Hovasse, Martine Gilard, Bernard Jouve, Jacques Berlan, Irme Ungi, Patrick Ohlmann, Jean Armengaud, Talib Majwal, Pierre Cazaux, Arif A.L. Noryani, Claude Cassat, O. Ormezzano, Didier Carrié, Hussam A. Noor
Publikováno v:
JACC: Cardiovascular Interventions
JACC: Cardiovascular Interventions, Elsevier/American College of Cardiology, 2017, 10 (12), pp.1202-1210. ⟨10.1016/j.jcin.2017.03.049⟩
JACC: Cardiovascular Interventions, Elsevier/American College of Cardiology, 2017, 10 (12), pp.1202-1210. ⟨10.1016/j.jcin.2017.03.049⟩
Objectives The aim of this study was to test the hypothesis that 6-month dual antiplatelet therapy (DAPT) is noninferior to 24-month DAPT in aspirin-sensitive patients. Background The ITALIC (Is There a Life for DES After Discontinuation of Clopidogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::568efe475d3813e85a3d837589212009
https://doi.org/10.1016/j.jcin.2017.03.049
https://doi.org/10.1016/j.jcin.2017.03.049
Autor:
Hervé Le Breton, Simon Elhadad, Frédéric Marco, Said Ghostine, Sylvain Ranc, Philippe Garot, Jean Fajadet, Luc Maillard, Francois Tarragano, Didier Carrié, Thierry Lefèvre, Pascal Motreff, René Koning, Guillaume Cayla, Joel Sainsous
Publikováno v:
Archives of cardiovascular diseases
Archives of cardiovascular diseases, 2019, 112 (2), pp.113-123. ⟨10.1016/j.acvd.2018.09.007⟩
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2019, 112 (2), pp.113-123. ⟨10.1016/j.acvd.2018.09.007⟩
Archives of cardiovascular diseases, 2019, 112 (2), pp.113-123. ⟨10.1016/j.acvd.2018.09.007⟩
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2019, 112 (2), pp.113-123. ⟨10.1016/j.acvd.2018.09.007⟩
International audience; Background - Several randomized studies have shown that bioresorbable vascular scaffold (BVS) technology is associated with an increased risk of stent thrombosis. Aim - This study aimed to assess the rates of adverse outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc04e599ba80a13cdcfa44b4d843806a
https://univ-rennes.hal.science/hal-01998544/document
https://univ-rennes.hal.science/hal-01998544/document
Autor:
Hervé Le Breton, Didier Carrié, Bernard Jouve, Didier Champagnac, Antoine Gommeaux, Pierre Cazaux, Raphael Dauphin, Erwan Bressolette, Patrick Dupouy, Philippe Druelles, Philippe Castellant, Anne Lyuycx-Bore, Paul Barragan, Jean Armengaud, Franck Paganelli, Michel Schneeberger, Hakim Benamer, Joel Sainsous, Arif A.L. Noryani, Alain Kermarrec, Didier Blanchard, Jacques Berland, Thomas Hovasse, O. Ormezzano, Knut Endresen, Martine Gilard, Claude Cassat, Imre Ungi, Marie-Claude Morice, Gilles Levy, Alain Furber, Jacques Boschat, Patrick Ohlmann, Luc Maillard, Róbert Gábor Kiss, Talib Majwal, Hussam A. Noor, Nicolas Delarche, Oliver Darremont, Jarosław Wójcik
Publikováno v:
Journal of the American College of Cardiology. 65:777-786
Background The currently recommended duration of dual antiplatelet therapy (DAPT) in drug-eluting stent (DES) recipients is 12 months to reduce the risk of late stent thrombosis, particularly in those with acute coronary syndrome (ACS). Objectives Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f074c7142f8eb1b6b24b6555a67114f1
https://doi.org/10.1016/j.jacc.2014.11.008
https://doi.org/10.1016/j.jacc.2014.11.008
Autor:
Catherine Meuleman, Joel Sainsous, Francois Xavier Hager, Frederic Ortuno, Gilles Bayet, Ghislaine Dufaitre, Laurent Meille, Jerome Brunet
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 8:10-11
Background Between February 2013 and May 2015, of 2,700 coronary angioplasty procedures realized in our institution, 200 patients aged 65.6 (23-94) underwent coronary stenting with Absorb Biovascular Scaffold. Clinical data exercise angina in 30% of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce75ba1e3eed16064a9f54aa6c953862
https://doi.org/10.1016/s1878-6480(16)30032-5
https://doi.org/10.1016/s1878-6480(16)30032-5
Autor:
Sofiene Rekik, Francois Xavier Hager, Laurent Meille, Jean Michel Quatre, Gilles Bayet, Jérôme Brunet, Joel Sainsous
Publikováno v:
Clinical Research in Cardiology. 100:629-631
Pedicled gastroepiploic artery (GEA) may be used as an arterial conduit in selected patients undergoing total arterial coronary bypass grafting [1]. Myocardial ischemia may result from spasm, occlusion, and stenosis of the graft [2]. The anastomosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a34c153f281daedfb0b48f196c7ee62
https://doi.org/10.1007/s00392-011-0307-2
https://doi.org/10.1007/s00392-011-0307-2
Autor:
Paul Barragan, Marc Silvestri, Pierre-Olivier Roquebert, Jean-Baptiste Simeoni, Gilles Bayet, Jean-Louis Bouvier, Jean-Michel Quatre, Bertrand Comet, Joel Sainsous
Publikováno v:
Catheterization and Cardiovascular Diagnosis. 42:367-373
Between March 1994 and November 1995, 1,212 coronary stents were implanted in 1,051 consecutive patients at our institution with the following protocol: daily pre- and poststenting treatment with ticlopidine 500 mg without aspirin, implantation under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f4da7264e20fdd4e2998a95f3a62097
https://doi.org/10.1002/(sici)1097-0304(199712)42:4<367::aid-ccd1>3.0.co
https://doi.org/10.1002/(sici)1097-0304(199712)42:4<367::aid-ccd1>3.0.co
Autor:
Jean Michel Quatre, Joel Sainsous, Gilles Bayet, Sofiene Rekik, Francois Xavier Hager, Jerome Brunet, Laurent Meille
Publikováno v:
The Canadian journal of cardiology. 29(11)
Background Lower extremity ischemia after the use of vascular closure devices (VCDs) after transfemoral percutaneous coronary and peripheral interventions is an infrequent though relevant clinical entity. We aimed to assess immediate and midterm outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c3097216ef0d6671f9f533820f8409
https://pubmed.ncbi.nlm.nih.gov/23988339
https://pubmed.ncbi.nlm.nih.gov/23988339
Publikováno v:
Journal of the American College of Cardiology. 68:B21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c1a8dd2e1cc13b7309296f56bf36beb
https://doi.org/10.1016/j.jacc.2016.09.196
https://doi.org/10.1016/j.jacc.2016.09.196
Autor:
Jerome Brunet, Gille Bayet, Joel Sainsous, Jean Michel Quatre, Sofiene Rekik, Francois Xavier Hager, Laurent Meille
Publikováno v:
Journal of the American College of Cardiology. 57(14)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd97f19f18ad4d18cb9283d5b870b318
Autor:
Jerome Brunet, Joel Sainsous, Jean Michel Quatre, Laurent Meille, Gilles Bayet, Sofiene Rekik, Francois Xavier Hager
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 3(1)
BackgroundAlthough cardiac surgery is still considered as the gold standard of care for patients with unprotected left main coronary artery (ULMCA) disease, percutaneous coronary intervention (PCI) is emerging as a possible alternative.AimTo evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8579d231c7c1991c08ba24cd030896bc